Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lung Donation After Controlled Circulatory Determination of Death: A Review of Current Practices and Outcomes.

Transplantation proceedings·2015
Same author

Successful lung salvage by ex vivo reconditioning of neurogenic pulmonary edema: case report.

Transplantation proceedings·2014
Same author

Cardiac Transplants With Cyclosporin-A and Low-Dose Prednisone: Histologic Graduation of Rejection.

Transplantation proceedings·2014
Same author

Gender differences in patterns of emotional distress following heart transplantation.

Journal of clinical psychology in medical settings·2013
Same author

Improved Cardiac Function Using Cardioplegia During Procurement and Transplantation.

Transplantation proceedings·2010
Same author

Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement.

Transplantation proceedings·2010

相关实验视频

Updated: Jul 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

通过超诱导可诱导的氧化合成酶来减轻心肌缺血/反损伤.

S Kanno1, P C Lee, Y Zhang

  • 1Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, USA. skanno@andrew.cmu.edu

Circulation
|June 14, 2000
PubMed
概括

氧化 (NO) 通过防止高动态反应,防止心肌缺血/反 (I/R) 损伤. 使用淘汰赛小鼠和NO调节器的研究证实了NO在I/R事件期间对心脏功能的保护作用.

更多相关视频

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

相关实验视频

Last Updated: Jul 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

科学领域:

  • 心血管科学 心血管科学
  • 生理学 生理学 生理学
  • 生物化学 生物化学

背景情况:

  • 关于氧化物 (NO) 在心肌缺血/反 (I/R) 损伤中的参与,有争议.
  • 研究了NO对I/R损伤的保护潜力.

研究的目的:

  • 为了确定氧化 (NO) 是否能保护心肌缺血/反 (I/R) 损伤.
  • 阐明NO在心脏I/R中的作用背后的机制.

主要方法:

  • 使用内皮NO合成酶 (eNOS) 淘汰和可诱导NOS (iNOS) 淘汰的小鼠.
  • 在接受I/R的隔离 perfused心脏模型中使用了NO供体 (SNAP) 和NOS抑制剂 (L-NIO).
  • 评估心肌损伤,心脏病发作大小和I/R后收缩功能.

主要成果:

  • 在SNAP和eNOS KO组中观察到高酸盐水平在再输液后.
  • eNOS KO心脏显示了iNOS超诱导,表明了适应性反应.
  • 增加的NO活性与降低的高动力反应,心肌损伤和心脏病发作大小相关.
  • 通过SNAP治疗可以保持心脏功能,而在长时间的再输血过程中,L-NIO会损害心脏功能.

结论:

  • 通过减轻超动态收缩反应,NO显示出对I/R损伤的保护作用.
  • 在eNOS KO心脏中,NO生产和iNOS超诱导的矛盾增加表明了适应性补偿机制.